Resources

With already increased risk of weight gain in adolescents with type 1 diabetes, certain traits in these children can also be markers for even higher weight gain…. 

Available studies to date looking at the benefits of using SGLT-2 inhibitors have shown positive results…. The discovery of sodium-glucose co-transporter 2 (SGLT2) inhibitors, with a novel mechanism independent of insulin secretion or sensitization, offered a new therapeutic approach for the management of type 2 diabetes mellitus. The aim of this …

Patients with diabetes and stable angina may reap the benefits of ranolazine…. 

Adolescents with type 2 diabetes are at risk of atherosclerosis and cardiovascular disease early on in life…. 

A daughter’s poor health may lead to an increased risk in their parent’s health…. 

Natesto is the first-ever testosterone replacement therapy administered via intranasal….

  In this week’s Homerun Slides, we continue our discussion of the Role of the Kidneys with topics including the Unmet Needs in Diabetes Care, Incidence of Microvascular Complications in IGT, and a review of the Steno-2 study….

Richard S. Beaser, MD This week’s excerpt covers the following topics: What drugs block glucose absorption How to titrate this class of drugs Learn the contraindications and precautions for the glucose blocking drugs Discover which other drugs can cause serious side effects when used with drugs that block glucose absorption   …

HypoMap – A new tool to prevent hypoglycemia  At the ADA meeting next week, diabetes management software company Glooko and the Joslin Diabetes Center will launch HypoMap, a new patient-facing platform to help increase patients’ awareness of hypoglycemic events. The platform will include an app for patients with diabetes that will …

Ten percent of patients were newly diagnosed with diabetes while being treated for their heart attack….